{"news_desk": "Business", "print_page": "3", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By MATTHEW GOLDSTEIN and ALEXANDRA STEVENSON", "person": [{"rank": 1, "role": "reported", "firstname": "Matthew", "organization": "", "lastname": "GOLDSTEIN"}, {"rank": 2, "role": "reported", "firstname": "Alexandra", "organization": "", "lastname": "STEVENSON"}]}, "abstract": "Martin Shkreli, according to his defense lawyer Benjamin Brafman, has been advised to keep low profile in court, on social media and with news media; Brafman says his client will assert his Fifth Amendment rights during scheduled testimony before House Committee on Oversight and Government Reform.", "type_of_material": "News", "word_count": "683", "lead_paragraph": "Mr. Shkreli\u2019s new defense lawyer, Benjamin Brafman, said he had advised his client, who faces securities fraud charges, to stop talking to the media and posting on Twitter.", "pub_date": "2016-02-04T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Martin Shkreli Appears to Adopt a New Legal Strategy: Silence", "print_headline": "Accepting Lower Profile, Shkreli Appears in Court"}, "snippet": "Mr. Shkreli\u2019s new defense lawyer, Benjamin Brafman, said he had advised his client, who faces securities fraud charges, to stop talking to the media and posting on Twitter.", "multimedia": [{"height": 126, "url": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 440, "url": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "440", "xlarge": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/02/04/business/martin-shkreli-appears-to-adopt-a-new-legal-strategy-silence.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Shkreli, Martin (1983- )", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "Securities and Commodities Violations", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "KaloBios Pharmaceuticals Inc.", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Retrophin Inc", "name": "organizations"}, {"rank": "6", "is_major": "Y", "value": "Turing Pharmaceuticals AG", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Brafman, Benjamin", "name": "persons"}], "blog": [], "_id": "56b26d2b38f0d82036f0a842", "source": "The New York Times"}